NanoViricides Inc. (NNVC): Scale up is certainly not complete nor p...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Monday, 07/28/2014 3:20:43 PM

Monday, July 28, 2014 3:20:43 PM

Scale up is certainly not complete nor perfected (though we've been told both are done).

Unsupported myth - as we have been definitively told no such thing.

Seymour working 18 hour days from Santa Monica hasn't seemed to help.

Hyperbole

Diwan makes huge profit selling facility back to nnvc,

A statement for which there is no actual support.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM

InvestorsHub NewsWire

Only $200 per official company press release!